Abstract:Background The off-label use of antipsychotic medications is common in many countries, and the extent of such use in psychiatric inpatients in China has not been sufficiently studied. The purpose of this study was to survey the incidence and examine the correlates of off-label antipsychotic use in a large, nationally–representative sample in China. Methods This study included discharged psychiatric patients between March 19 and 31, 2019 from 41 tertiary psychiatric hospitals across 29 provinces in China. Their socio-demographic and clinical data were collected and analyzed. Results After excluding patients with schizophrenia spectrum disorder or bipolar disorder, 981 patients were included in the analysis. Overall, antipsychotics were prescribed to 63.2% (95%CI 60.2–66.2%) of the sample. Antipsychotics were used in a wide spectrum of psychiatric disorders, with the rate being the highest among patients with dissociative (conversion) disorders (89.9, 95%CI 83.0–94.8%), organic mental disorders (81.7, 95%CI 73.1–88.7%), dementia (79.0,95%CI 67.8–87.9%), obsessive-compulsive disorder (77.8, 95%CI 55.7–92.5%), mental disorders due to psychoactive substances (75.3,95%CI 64.7–84.2%), behavioural and emotional disorders with onset usually occurring in childhood and adolescence (71.4, 95%CI 45.5–90.1%), somatoform disorders (63.2, 95%CI 40.8%–82..2%), major depression disorder (53.7,95%CI 48.8–58.6%), anxiety disorder (38.8,95%CI 30.5–47.7%), and insomnia (25.0, 95%CI 8.5–28.9%). The top three most commonly used antipsychotics were olanzapine (29.1%), quetiapine (20.3%) and risperidone (6.8%), and their corresponding average doses were 9.04 ± 5.80 mg/day, 185.13 ± 174.72 mg/day, and 2.98 ± 1.71 mg/day, respectively. A binary logistic regression showed that younger age, having the Employee Health Insurance or Residents Health Insurance, having psychotic symptoms and requiring restraint during hospitalization were significantly associated with off-label use of antipsychotics. Conclusion Off-label use of antipsychotics is very common in psychiatric inpatients in China, mainly with moderate-dose use of single agents. However, the efficacy and safety of this practice is uncertain for many diagnoses and for the elderly. Clinicians should be cautious about this practice while waiting for more research data.

A survey of antipsychotic usage in treatment of schizophrenia in China 2006

Patterns of Antipsychotic Prescriptions in Patients with Schizophrenia in China: A National Survey

Factors That Influence the Prescription of Antipsychotics for Patients with Schizophrenia in China.

Antipsychotic polypharmacy in schizophrenia patients in China and its association with treatment satisfaction and quality of life: findings of the third national survey on use of psychotropic medications in China.

The second cross-sectional study on antipsychotic drug patterns of schizophrenia in China

From strict quarantine to an optimized policy: Are we psychologically prepared?

Use of first- and second-generation antipsychotic medications in older patients with schizophrenia in Asia (2001-2009).

A survey of antipsychotics combination therapy and its related factors in China 2006

Antipsychotic prescription patterns among schizophrenia patients in Guangdong Province, China's 686 program: A retrospective study

Anticholinergic Use Trends in 14,013 Patients with Schizophrenia from Three National Surveys on the Use of Psychotropic Medications in China (2002–2012)

Sex Differences in Pharmacotherapy of Schizophrenia:Findings from National Survey 2012 on Use of Psychotropic Medications

Antipsychotic drug patterns of schizophrenia in China:a cross-sectioned study

Prescription Practices in the Treatment of Agitation in Newly Hospitalized Chinese Schizophrenia Patients: Data from a Non-Interventional Naturalistic Study

Antipsychotic Medications in Major Depression and the Association with Treatment Satisfaction and Quality of Life: Findings of Three National Surveys on Use of Psychotropics in China Between 2002 and 2012

Antipsychotic drug prescription for schizophrenia in East Asia: rationale for change.

Adjunctive Antidepressant Use In Schizophrenia In China: A National Survey (2002-2012)

Prescribing antipsychotic drugs for inpatients with schizophrenia in Asia: Comparison of REAP-2001 and REAP-2004 studies: Prescribing antipsychotics in REAP study

Trends of Antipsychotic Drugs Use in Schizophrenia Patients from Hebei Province

Use of clozapine for the treatment of schizophrenia: findings of the 2006 research on the china psychotropic prescription studies

Present Survey on Antipsychotic Medications to the Patients with Schizophrenia in Hebei Province

Off-label use of antipsychotic medications in psychiatric inpatients in China: a national real-world survey